CENTRUS ENERGY CORP annual report, FY2013

USEC Inc. 2013 Form 10-K Summary

Reporting period: Fiscal year ended December 31, 2013. The filing identifies the issuer as USEC Inc. (the company identified in the request as Centrus Energy Corp.). The March 5, 2014 Chapter 11 filing and proposed restructuring are subsequent events disclosed in this annual report.

Business context and reporting period

USEC supplied low-enriched uranium (LEU) to nuclear utilities, with revenue primarily from separative work units (SWU). The business underwent a major transition: enrichment at the Paducah plant stopped at the end of May 2013, and purchases under the 20-year Megatons to Megawatts Russian program ended in December 2013. A new 10-year Russian commercial supply agreement began in 2013. The American Centrifuge project remained in demonstration and development, without financing in place for commercial deployment.

Key financial metrics

Metric20132012
Revenue$1,307.5 million$1,862.1 million
Gross profit (loss)$(94.9) million$129.4 million
Gross margin(7.3)%6.9%
Operating loss$(230.7) million$(1,154.3) million
Net loss$(158.9) million$(1,200.6) million
Cash from operating activities$81.2 million$142.9 million
Cash and cash equivalents at year-end$314.2 million$292.9 million
Working capital (deficit)$(162.7) million$542.1 million
Stockholders’ equity (deficit)$(458.2) million$(472.9) million

Revenue fell 30%, including a 33% decline in SWU revenue; SWU sales volume fell 35%. The 2013 gross loss reflected lower sales and $194.2 million of LEU-segment non-production costs, including plant transition expenses, asset and inventory charges, and power-contract losses. The net loss included $24.7 million of income from discontinued operations, principally a $35.6 million gain on the sale of NAC.

Total assets were $1.71 billion, including $967.6 million of inventory; inventory was down from $1.59 billion in 2012. Current liabilities were $1.79 billion. The $530 million of 3.0% convertible senior notes, due October 1, 2014, were classified as current. The prior $110 million credit facility matured September 30, 2013 and was not replaced. Cash flow from operations declined despite a $160.1 million inventory reduction, in part because Russian supplier payables increased $130.9 million. No capital expenditures were recorded in 2013.

Defined-benefit pension plans were underfunded by approximately $123.4 million on a GAAP basis at year-end; postretirement health and life obligations were $195.0 million. The company expected to contribute $37.7 million to pension plans in 2014.

Material changes versus the prior comparable period

  • Revenue declined by $554.6 million, and the business moved from a positive gross margin to a gross loss as Paducah enrichment ceased and SWU sales volume contracted.
  • Operating loss improved substantially from 2012, principally because 2012 included a $1.1 billion write-off of previously capitalized American Centrifuge costs. This improvement did not indicate a return to profitability: 2013 still had a net loss and negative gross margin.
  • Cash increased by $21.3 million during 2013, versus a $255.3 million increase in 2012; operating cash flow fell by $61.7 million.
  • Customer backlog declined to an estimated $3.3 billion from $4.5 billion. Approximately $400 million was expected to be delivered and recognized as revenue in 2014; about 30% of backlog was considered exposed to American Centrifuge financing or deployment milestones.
  • USEC sold NAC in March 2013 and reported its results as discontinued operations.

Outlook, restructuring, risks and unusual items

  • Chapter 11 and proposed plan: USEC Inc. filed a pre-arranged Chapter 11 petition on March 5, 2014; its operating subsidiaries, including United States Enrichment Corporation, were not debtors. The proposed plan would exchange $530 million of notes for $200 million of new notes and 79.04% of reorganized common stock for noteholders; preferred investors would receive an aggregate 15.96% of new common stock and $40.38 million of new notes. Existing common shareholders would receive 5% of new common stock if the requisite creditor and preferred-investor votes are obtained. The plan remained subject to court confirmation and other conditions.
  • Liquidity and going concern: The auditor’s report highlights substantial doubt about the company’s ability to continue as a going concern. Management said 2014 liquidity was uncertain and depended on the restructuring, subsidiary funding, DOE reimbursements, customer delivery timing, Paducah transition costs, and the future of the centrifuge program. The filing forecast at least $60 million of cash at March 31, 2014 after significant first-quarter payables. An interim $50 million debtor-in-possession facility from the operating subsidiary carried 10.5% interest; interim court approval authorized draws up to $20 million pending final approval.
  • Business outlook: Management expected 2014 SWU sales volume to be about one-third of the prior 10–12 million SWU annual level, with lower revenue for at least several years. Approximately $400 million of backlog deliveries were expected to be recognized in 2014. The filing did not provide a comprehensive earnings or revenue forecast.
  • American Centrifuge and DOE support: All ten RD&D technical milestones were reported complete, but funding was provided only through April 15, 2014, and DOE stated it did not plan to extend the agreement. Commercialization was not considered economic at prevailing market prices without additional government support. Management estimated at least $4 billion would be needed for commercial deployment and warned that demobilization or termination could occur.
  • Supply, market and contract risks: LEU prices were at their lowest levels in more than a decade amid oversupply and delayed reactor restarts. Russian supply purchases could exceed contracted customer demand; import quotas, customer acceptance, pricing above market, and geopolitical developments could constrain resale or deliveries. Ten customers represented 69% of 2013 revenue; Energy Northwest alone represented about 20%.
  • Contingencies and unusual costs: USEC accrued $30.4 million for Paducah lease turnover and estimated up to $20.8 million of severance costs for remaining Paducah employees, before a potential DOE share. The PBGC asserted a preliminary potential ERISA Section 4062(e) liability of about $130 million related to Portsmouth; potential Paducah exposure could be greater, but was unresolved and disputed. The company also reported $98.4 million of gross receivables from DOE or DOE contractors, including $80.8 million in certified claims, with significant valuation allowances on long-term claims.
  • Other investor considerations: About $39.8 million of cash collateral supported surety bonds. The NYSE had accepted a compliance plan addressing market capitalization; failure to meet milestones could lead to trading suspension. The filing said the common-stock minimum-price issue had been cured by a 1-for-25 reverse split.

Important facts for investors to verify

  • Whether the Chapter 11 plan was confirmed and became effective, and the final recovery and dilution for existing common shareholders.
  • Actual post-April 15, 2014 DOE funding, the status of the centrifuge demonstration and any decision to continue, demobilize or terminate the project.
  • Actual cash generation and liquidity, including use and repayment of the DIP facility, availability of exit financing, and the operating subsidiary’s ability to support the parent.
  • Customer deliveries, backlog changes and contract modifications or terminations, particularly the estimated 30% of backlog exposed to ACP milestones.
  • Paducah de-lease timing and final turnover, severance and other transition costs, plus the outcome of PBGC discussions and DOE pension-cost claims.
  • Russian LEU delivery and resale economics, import-quota constraints, and the impact of geopolitical or regulatory developments.